title: RE: Non-specific effects of co-administration of live measles, yellow fever and pentavalent vaccines on mortality?
authors.affiliation: Clinical Development and Medical Affairs, Crucell Switzerland AG, Bern CH-3018 Switzerland. Electronic address: DSchmid1@its.jnj.com.
authors.forename: Daphné A
authors.initials: DA
authors.lastname: Schmid
authors.affiliation: Clinical Development and Medical Affairs, Crucell Switzerland AG, Bern CH-3018 Switzerland.
authors.forename: Patricia
authors.initials: P
authors.lastname: Ibarra de Palacios
authors.affiliation: Clinical Biostatistics, Janssen Research and Development LLC, Titusville, NJ 08560, United States.
authors.forename: Ralph
authors.initials: R
authors.lastname: DeMasi
mesh_terms: D015721:Diphtheria-Tetanus-Pertussis Vaccine / Q000008:administration & dosage*; D005260:Female; D018073:Haemophilus Vaccines / Q000008:administration & dosage*; D017325:Hepatitis B Vaccines / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008458:Measles Vaccine / Q000008:administration & dosage*; D009026:Mortality; D022341:Yellow Fever Vaccine / Q000008:administration & dosage*
chemical_list: D015721:Diphtheria-Tetanus-Pertussis Vaccine; D018073:Haemophilus Vaccines; D017325:Hepatitis B Vaccines; D008458:Measles Vaccine; D022341:Yellow Fever Vaccine